New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients - Poll - MDSpire

New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients

While an estimated 95% of “younger” patients diagnosed with Hodgkin lymphoma are still alive and into survivorship within five years of their diagnosis, their long-term health suffers from the aggressive treatment needed to fight the disease.

November 10, 2025

Roswell Park Comprehensive Cancer Center

Share

Original Source(s)

Roswell Park Comprehensive Cancer Center

New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients

November 10, 2025

Related Content

Bmc Cancer

Retraction Note: TWIST1 activates cancer stem cell marker genes to promote epithelial‑mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma

by Sima Ardalan Khales, Sina Mozaffari‑Jovin, Dirk Geerts, Mohammad Reza Abbaszadegan
September 11, 2026

The Medicine Maker

CAR T Before Surgery Improves Glioblastoma Control in Mice

Study finds that tumor resection creates a more immunosuppressive environment and that earlier CAR T cell treatment prolongs survival

September 7, 2026
3 min

Fox Chase Cancer Center

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.

by
September 4, 2026
4 min